Editorial questions, corrections, and confidential tips for the Novusyn Research peptide intelligence desk should be sent to editor@novusynresearch.com. We respond to verified press inquiries, regulator and sponsor right-of-reply requests, and academic-source questions within two business days. For partnership, licensing, or syndication inquiries, please indicate “Partnerships” in the subject line.
The desk does not provide medical advice, drug-information services, prescriptions, or peptide-acquisition assistance. We are not a pharmacy, distributor, or compounder. Questions about specific therapeutic decisions should be directed to a licensed clinician. For background on how the desk operates, see our Editorial Standards.